Determination of the Phosphorylated Metabolites of Gemcitabine and of Difluorodeoxyuridine by LCMSMS

REFERENCES

• Bergman , A. M. , Pinedo , H. M. and Peters , G. J. 2002 . Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine) . Drug Resist. Updat. , 5 : 19 – 33 .
   PubMed Web of Science ®Google Scholar
• Huang , P. , Chubb , S. , Hertel , L. W. , Grindey , G. B. and Plunkett , W. 1991 . Action of 2′,2′-difluorodeoxycytidine on DNA synthesis . Cancer Res , 51 : 6110 – 6117 .
   PubMed Web of Science ®Google Scholar
• Cardenes , H. R. , Chiorean , E. G. , Dewitt , J. , Schmidt , M. and Loehrer , P. 2006 . Locally advanced pancreatic cancer: current therapeutic approach . Oncologist , 11 : 612 – 623 .
   PubMed Web of Science ®Google Scholar
• Kroep , J. R. , Peters , G. J. and Nagourney , R. A. 2007 . “ Clinical activity of gemcitabine as a single agent and in combination ” . In Deoxynucleoside Analogs in Cancer Therapy , Edited by: Peters , G. J. 253 – 288 . Humana Press .
   Google Scholar
• Kose , M. F. , Meydanli , M. M. and Tulunay , G. 2006 . Gemcitabine plus carboplatin in platinum-sensitive recurrent ovarian carcinoma . Expert Rev. Anticancer Ther. , 6 : 437 – 443 .
   PubMed Web of Science ®Google Scholar
• von der Maase , H. , Hansen , S. W. , Roberts , J. T. , Dogliotti , L. , Oliver , T. and Moore , M. J. 2000 . Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study . J. Clin. Oncol. , 18 : 3068 – 3077 . et al
   PubMed Web of Science ®Google Scholar
• Heinemann , V. , Hertel , L. W. , Grindey , G. B. and Plunkett , W. 1988 . Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine . Cancer Res , 48 : 4024 – 4031 .
   PubMed Web of Science ®Google Scholar
• De Lange , S. M. , Van der Born , K. , Kroep , J. R. , Jensen , H. A. , Pfeiffer , P. and Cleverly , A. 2005 . No evidence of gemcitabine accumulation during weekly administration . Eur. J. Clin. Pharmacol , 61 : 843 – 849 . et al
   PubMed Web of Science ®Google Scholar
• de Lange , S. M. , Van Groeningen , C. J. , Kroep , J. R. , Van Bochove , A. , Snijders , J. F. and Peters , G. J. 2004 . Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer . Ann. Oncol. , 15 : 484 – 488 . et al
   PubMed Web of Science ®Google Scholar
• Peters , G. J. , Clavel , M. , Noordhuis , P. , Geyssen , G. J. , Laan , A. C. and Guastalla , J. 2007 . Clinical phase I and pharmacology study of gemcitabine (2′, 2′-difluorodeoxycytidine) administered in a two-weekly schedule . J. Chemother. , 19 : 212 – 221 . et al
   PubMed Web of Science ®Google Scholar
• Veltkamp , S. A. , Pluim , D. , van Eijndhoven , M. A. , Bolijn , M. J. , Ong , F. H. and Govindarajan , R. 2008 . New insights into the pharmacology and cytotoxicity of gemcitabine and 2′,2′-difluorodeoxyuridine . Mol. Cancer Ther. , 7 : 2415 – 2425 . et al
   PubMed Web of Science ®Google Scholar
• Veltkamp , S. A. , Hillebrand , M. J. , Rosing , H. , Jansen , R. S. , Wickremsinhe , E. R. and Perkins , E. J. 2006 . Quantitative analysis of gemcitabine triphosphate in human peripheral blood mononuclear cells using weak anion-exchange liquid chromatography coupled with tandem mass spectrometry . J. Mass Spectrom. , 41 : 1633 – 1642 . et al
   PubMed Web of Science ®Google Scholar
• Veltkamp , S. A. , Jansen , R. S. , Callies , S. , Pluim , D. , Visseren-Grul , C. M. and Rosing , H. 2008 . Oral administration of gemcitabine in patients with refractory tumors: a clinical and pharmacologic study . Clin. Cancer Res. , 14 : 3477 – 3486 . et al
   PubMed Web of Science ®Google Scholar
• Jansen , R. S. , Rosing , H. , Schellens , J. H. and Beijnen , J. H. 2009 . Simultaneous quantification of 2′,2′-difluorodeoxycytidine and 2′,2′-difluorodeoxyuridine nucleosides and nucleotides in white blood cells using porous graphitic carbon chromatography coupled with tandem mass spectrometry . Rapid Commun. Mass Spectrom. , 23 : 3040 – 3050 .
   PubMedGoogle Scholar
• Sigmond , J. , Honeywell , R. J. , Postma , T. J. , Dirven , C. M. , de Lange , S. M. and van der Born , K. 2009 . Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer . Ann. Oncol. , 20 : 182 – 187 . et al
   PubMed Web of Science ®Google Scholar
• Honeywell , R. , Laan , A. C. , van Groeningen , C. J. , Strocchi , E. , Ruiter , R. and Giaccone , G. 2006 . The determination of gemcitabine and 2′-deoxycytidine in human plasma and tissue by APCI tandem mass spectrometry . J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. , 847 : 142 – 152 . et al
   PubMedGoogle Scholar
• Song , L. , James , S. R. , Kazim , L. and Karpf , A. R. 2005 . Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry . Anal. Chem. , 77 : 504 – 510 .
   PubMed Web of Science ®Google Scholar
• Zor , T. and Selinger , Z. 1996 . Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies . Anal. Biochem. , 236 : 302 – 308 .
   PubMed Web of Science ®Google Scholar
• Shewach , D. S. 1992 . Quantitation of deoxyribonucleoside 5′-triphosphates by a sequential boronate and anion-exchange high-pressure liquid chromatographic procedure . Anal. Biochem. , 206 : 178 – 182 .
   PubMed Web of Science ®Google Scholar
• Dreyer , R. and Cadman , E. 1981 . Use of periodate and methylamine for the quantitation of intracellular 5-fluoro-2′-deoxyuridine-5′-monophosphate by high-performance liquid chromatography . J. Chromatogr. , 219 : 273 – 284 .
   PubMedGoogle Scholar
• Peters , G. J. , de Abreu , R. A. , Oosterhof , A. and Veerkamp , J. H. 1983 . Concentration of nucleotides and deoxynucleotides in peripheral and phytohemagglutinin-stimulated mammalian lymphocytes. Effects of adenosine and deoxyadenosine . Biochim. Biophys. Acta , 759 : 7 – 15 .
   PubMed Web of Science ®Google Scholar
• Smid , K. , Van Moorsel , C. J. , Noordhuis , P. , Voorn , D. A. and Peters , G. J. 2001 . Interference of gemcitabine triphosphate with the measurements of deoxynucleotides using an optimized DNA polymerase elongation assay . Int. J. Oncol. , 19 : 157 – 162 .
   PubMedGoogle Scholar
• Ruiz Van Haperen , V. , Veerman , G. , Boven , E. , Noordhuis , P. , Vermorken , J. B. and Peters , G. J. 1994 . Schedule dependence of sensitivity to 2′,2′-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours . Biochem. Pharmacol. , 48 : 1327 – 1339 .
   PubMed Web of Science ®Google Scholar
• Adema , A. D. , Losekoot , N. , Smid , K. , Kathmann , I. , Myhren , F. and Sandvold , M. L. 2010 . Induction of resistance to the lipophilic cytarabine prodrug elacytarabine (CP-4055) in CEM leukemic cells . Nucleosides Nucleotides Nucleic Acids , 29 : 394 – 399 . et al
   PubMed Web of Science ®Google Scholar
• Kichenin , K. , Pignede , G. , Fudalej , F. and Seman , M. 2000 . CD3 activation induces concentrative nucleoside transport in human T lymphocytes . Eur. J. Immunol. , 30 : 366 – 370 .
   PubMedGoogle Scholar
• Bijnsdorp , I. V. , Schwendener , R. A. , Schott , H. , Fichtner , I. , Smid , K. and Laan , A. C. 2011 . Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2′-deoxyuridine . Invest. New Drugs , 29 : 248 – 257 . et al
   PubMedGoogle Scholar
• Van Moorsel , C. J. , Smid , K. , Voorn , D. A. , Bergman , A. M. , Pinedo , H. M. and Peters , G. J. 2003 . Effect of gem- citabine and cis-platinum combinations on ribonucleotide and deoxyribonucleotide pools in ovarian cancer cell lines . Int. J. Oncol. , 22 : 201 – 207 .
   PubMed Web of Science ®Google Scholar
• Zhang , W. , Tan , S. , Paintsil , E. , Dutschman , G. E. , Gullen , E. A. and Chu , E. 2011 . Analysis of deoxyribonucleotide pools in human cancer cell lines using a liquid chromatography coupled with tandem mass spectrometry technique . Biochem. Pharmacol. , 82 : 411 – 417 . et al
   PubMedGoogle Scholar